Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2022-04-29 | Rajesh Shrotriya, M.D. (2) 2021 178,671 178,671 |
| 2022-08-17 | Rajesh Shrotriya, M.D. |
| 2023-05-01 | Rajesh Shrotriya, M.D. - Director |
| 2023-11-06 | Rajesh Shrotriya, M.D. (4) Consists of shares options to purchase 919,809 shares of common stock. |
| 2024-04-29 | Dr. Shrotriya was appointed to our Board of Directors on January 13, 2021. Prior to joining our company, Dr. Shrotriya served as Chairman of the Board and Chief Executive Officer of Spectrum Pharmaceuticals, Inc. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22